We are live on ! Find out more
BCM

Boone Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
+10.04%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$428M
AUM Growth
+$111M
Cap. Flow
+$77.6M
Cap. Flow %
18.11%
Top 10 Hldgs %
66.3%
Holding
22
New
9
Increased
7
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$26.1M
2
AMPH icon
Amphastar Pharmaceuticals
AMPH
+$21M
3
VTRS icon
Viatris
VTRS
+$18.3M
4
BERY
Berry Global Group, Inc.
BERY
+$14.2M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$11.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$24.7M
2
MOH icon
Molina Healthcare
MOH
+$15.8M
3
CI icon
Cigna
CI
+$11.8M
4
DHR icon
Danaher
DHR
+$7.92M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$1.16M

Sector Composition

Rank Sector Weight
1 Healthcare 84.64%
2 Financials 10.15%
3 Materials 3.64%
4 Technology 1.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNM icon
1
Unum
UNM
$13.7B
$43.5M 10.15%
961,661
+94,096
+11% +$4.29M
ENOV icon
2
Enovis
ENOV
$1.66B
$31.5M 7.36%
562,739
+60,008
+12% +$2.99M
AMGN icon
3
Amgen
AMGN
$207B
$29.2M 6.82%
101,508
+3,382
+3% +$921K
CVS icon
4
CVS Health
CVS
$135B
$29M 6.77%
+367,370
New +$26.1M
GMED icon
5
Globus Medical
GMED
$10.7B
$28.2M 6.59%
529,825
+101,373
+24% +$4.94M
CI icon
6
Cigna
CI
$75.1B
$26.8M 6.27%
89,640
-40,277
-31% -$11.8M
DHR icon
7
Danaher
DHR
$137B
$25.1M 5.86%
108,501
-37,195
-26% -$7.92M
AMPH icon
8
Amphastar Pharmaceuticals
AMPH
$868M
$24.7M 5.77%
+400,000
New +$21M
MOH icon
9
Molina Healthcare
MOH
$10.2B
$24.7M 5.76%
68,288
-44,890
-40% -$15.8M
BAX icon
10
Baxter International
BAX
$13.5B
$21.2M 4.95%
548,536
+79,131
+17% +$2.8M
VTRS icon
11
Viatris
VTRS
$20.4B
$20.7M 4.83%
+1,912,272
New +$18.3M
IDYA icon
12
IDEAYA Biosciences
IDYA
$3.44B
$18.9M 4.42%
531,967
-38,715
-7% -$1.16M
BBIO icon
13
BridgeBio Pharma
BBIO
$15.6B
$17.8M 4.15%
440,845
+127,464
+41% +$3.83M
BERY
14
DELISTED
Berry Global Group, Inc.
BERY
$15.6M 3.64%
+252,056
New +$14.2M
QTRX icon
15
Quanterix
QTRX
$160M
$15.5M 3.63%
568,544
– –
MIRM icon
16
Mirum Pharmaceuticals
MIRM
$6.55B
$14.5M 3.38%
490,139
+100,348
+26% +$3.04M
XENE icon
17
Xenon Pharmaceuticals
XENE
$6.07B
$11.8M 2.75%
+255,432
New +$9.02M
BIO icon
18
Bio-Rad Laboratories Class A
BIO
$8.58B
$11.5M 2.69%
+35,713
New +$11.2M
OFIX icon
19
Orthofix Medical
OFIX
$467M
$6.74M 1.57%
+500,000
New +$5.87M
MLAB icon
20
Mesa Laboratories
MLAB
$549M
$6.71M 1.57%
+64,064
New +$6.24M
PNTG icon
21
Pennant Group
PNTG
$1.4B
$4.59M 1.07%
+329,660
New +$4.12M
BIIB icon
22
Biogen
BIIB
$30.2B
– –
-96,115
Closed -$24.7M

Similar funds

ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
AFA
Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
TC
TFR Capital Plano, Texas $326M AUM 24.24% 1-Year Est. Return

Boone Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Boone Capital Management held 22 positions worth $428M, up 35% from $317M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Boone Capital Management deployed $77.6M of net new capital in Q4 2023, opening 9 new positions and adding to 7 existing holdings. Its largest new stake was CVS Health: 367,370 shares worth $29M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Molina Healthcare, an estimated $15.8M trimmed.

  • Boone Capital Management's largest Q4 2023 buy was CVS Health: 367,370 shares worth $29M.
  • Boone Capital Management added most to Globus Medical in Q4 2023, an estimated $4.94M increase.
  • Boone Capital Management's biggest Q4 2023 reduction was Molina Healthcare, cutting an estimated $15.8M.
  • Boone Capital Management fully exited Biogen in Q4 2023, selling an estimated $24.7M.
  • Boone Capital Management's ten largest holdings make up 66% of its $428M portfolio in Q4 2023.
  • Boone Capital Management opened 9 new positions and closed 1 in Q4 2023.
  • Boone Capital Management's portfolio value rose 35% quarter-over-quarter to $428M.

Based on Boone Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.